RECRUITING

Functional Improvement in OSA and COPD With a Telehealth LifeStyle and Exercise Intervention

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The investigators will conduct a Type I hybrid effectiveness-implementation study to test an integrated telehealth intervention among 400 overweight and obese patients with Chronic Obstructive Pulmonary Disease (COPD) and Obstructive Sleep Apnea (OSA). The investigators will include eligible participants receiving primary care at one of five Department of Veterans Affairs (VA) medical centers and their community-based outpatient clinics. The investigators will randomize patients in a 1:1 ratio to the multi-component intervention or "enhanced" usual care, stratifying by age (≥65 vs. \< 65) and site. Participants randomized to the intervention will receive an integrated, telehealth-delivered intervention composed of a self-directed lifestyle program and supervised pulmonary rehabilitation. At the end of 3 months, the investigators will offer to enter a recommendation for weight management medications on behalf of eligible intervention participants. In the post-core period (months 4-12), participants will continue to have as-needed access to the lifestyle coach. For participants randomized to the "enhanced" usual care group, study staff will prompt the patient's primary care provider to refer them to existing weight loss management and pulmonary rehabilitation programs. Follow-up will occur at virtual visits at 3 and 12 months. The primary effectiveness outcome at 1-year is quality of life measured by the SF-12 Physical Component Summary Score. Secondary effectiveness outcomes will include other measures of quality of life (including sleep related impairment), sleep disturbance, disease severity (COPD exacerbations and respiratory event index for OSA), depression, social support, weight loss and cardiovascular risk. In addition to assessing effectiveness, investigators will also conduct a concurrent implementation process evaluation using the RE-AIM framework.

Official Title

Functional Improvement in OSA and COPD With a Telehealth LifeStyle and Exercise Intervention

Quick Facts

Study Start:2024-07-29
Study Completion:2028-10-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06390345

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * COPD: Defined by presence of airflow obstruction (FEV1/FVC \< 0.70) on post-bronchodilator spirometry
  2. * ≥10 pack year history of tobacco use
  3. * Self-reported clinician diagnosis of OSA (or presence of OSA on research HSAT)
  4. * BMI ≥ 25 kg/m2
  5. * Symptoms of dyspnea defined by MMRC score of ≥2
  1. * Self-report of weight change \>15 lbs. during prior 3 months
  2. * Current active weight loss treatment, including: 1) research-based commercial weight loss programs (e.g., Weight Watchers, Jenny Craig, HMR, Omada, TOPS, MOVE!); 2) other weight loss or related behavioral health or wellness programs led by trained personnel (professional or lay) in the local community; 3) prescription weight loss medication within last 3 months; and scheduled bariatric surgery.
  3. * Severe illness from any cause
  4. * Diagnosis of bulimia or history of purging behavior
  5. * Active enrollment in pulmonary rehabilitation
  6. * Safety and/or adherence concerns due to severe physical or mental health issues or life expectancy \< 12 months. These include but may not be limited to: unstable cardiac arrhythmias, active or recent (within one month) myocardial infarction, active or recent (within one month) COPD exacerbation, angina not well-controlled with medication, significant musculoskeletal comorbidities or physical infirmities that preclude participation in an exercise program, and the need for supplemental oxygen ≥ 5 lpm at rest or with exertion.
  7. * Pregnant, lactating, or planning to become pregnant during the study period
  8. * Participation in other intervention studies.
  9. * Prisoner
  10. * Unable to complete surveys in English

Contacts and Locations

Study Contact

Brianna Moss
CONTACT
206.277.4166
brianna.moss@va.gov

Study Locations (Sites)

Boise VA Medical Center
Boise, Idaho, 83702
United States
Jesse Brown VA Medical Center
Chicago, Illinois, 60612
United States
Minneapolis VA Health Care System
Minneapolis, Minnesota, 55417
United States
VA Puget Sound Health Care System
Seattle, Washington, 98108
United States
Mann-Grandstaff VA Medical Center
Spokane, Washington, 99205
United States

Collaborators and Investigators

Sponsor: Seattle Institute for Biomedical and Clinical Research

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-07-29
Study Completion Date2028-10-01

Study Record Updates

Study Start Date2024-07-29
Study Completion Date2028-10-01

Terms related to this study

Additional Relevant MeSH Terms

  • Chronic Obstructive Pulmonary Disease
  • Obstructive Sleep Apnea
  • Overweight and Obesity